News

 

Contact Media Relations

Office telephone: +39 0331 581380
mediarelations@nmsgroup.it

NerPharMa and ICROM sealed Partnership Agreement

Nerviano, 6 May 2021 NerPharMa, a veteran CDMO with a specialization in oncology small molecule drug manufacture and a member of NMS Group, has announced today a Partnership Agreement with ICROM srl, aiming for collaboration on commercial production of High Potent...

NMS Group wins China Awards for creating concrete values

Nerviano, 9 February 2021 NMS Group has been named the winner of the “Value creators' category at the prestigious 'China Awards 2021' during the online event held by the Italy China Foundation on Monday 8 February 2021. The “Value creators' award is a recognition for...

CANCER PATIENTS TO BENEFIT FROM NEW HISTOLOGY INDEPENDENT TREATMENT

25.06.2020 Entrectinib (Rozlytrek, Roche), a revolutionary treatment for a range of cancers, is the second histology independent drug to be recommended by NICE for use on the Cancer Drugs Fund (CDF). As a histology independent treatment, entrectinib targets all solid...

 Our Archive

MEDIA RELEASES & NEWS 2020
MEDIA RELEASES & NEWS 2019
MEDIA RELEASES & NEWS 2018
MEDIA RELEASES & NEWS 2020
MEDIA RELEASES & NEWS 2019
MEDIA RELEASES & NEWS 2018

 

Welcome and Check out our new motion picture!

WATCH OUR VIDEO